Abstract
Radioactive materials given to patients for the purpose of diagnosis are pharmaceuticals and are expected to give the same degree of safety as other pharmaceuticals. This means that when producing such pharmaceuticals only ingredients with certificate of origin and of pharmaceutical grade are used and all procedures are outlined in order to secure a final product meeting the demand of the user. This also include that possible risks can be estimated and compared with the benefit of the investigation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ICRP Publication 26, Pergamon Press 1977.
Johansson L, Mattsson S, Nosslin B. Stråledoser fran radioaktive ämnen i medicinskt bruk. Statens strålskydds institut. Box 60204, 104 01 Stockholm. 1981.
Barker S L. Safety testing. In Rhodes BA eds. Quality Control in Nucl. Med. The C.V. Mosby Company, Saint Louis. 1977.
Kristensen K. Quality Control Analysis at the Hospital. Radiopharmaceuticals II, Proceedings 2nd International Symposium on Radiopharmaceuticals, Seattle, Washington. Soc Nucl Med, New York. 1979.
Blaha V, Colombetti L G. Adverse Reactions to Radiotracers. Principles of Radiopharmaco1ogy. CRC Press Inc 1979; II:165–177.
Sullivan J D, Watson S N. Factors affecting the sensitivity of limulus lysate. Appl Microbiol 1974; 28:1023.
Murata H et al. Sensitivity of the limulus test and rehability factors in the Radiopharmaceuticals. J Nucl Med 1976; 17:1088–1092.
Kristensen, K. Preparation and Control of Radiopharmaceuticals in Hospitals. Technical Report series no. 194, IAEA Vienna. 1979.
Saba G B. Fundamental of Nuclear Pharmacy, New York. Springer Verlag. 1979.
Frier M, Hesslewood S R. Quality Assurance of Radiopharmaceuticals. Chapman and Hall in ass. with The British Nuclear Medicine Society. London. 1980.
Purity testing of Technetium 99m-preparations in the Clinical Laboratory. Hoechst. 1982.
Kristensen K. Quality Control of Radiopharmaceuticals in Medical Radionuclide Imaging. Vienna IAEA 1981; 2:59–78.
Wells E D, Bernier R D. Radionuclides Imaging Artifacts. Chicago. Year Book Medical Publishers. 1980.
Hamilton G W. Medical Decision marking and cost analysis in Cardiology. Proceedings of the third World Congress of Nuclear Medicine and Biology, Paris, Pergamon Press. 1982:1187–1190.
Rhodes A. Quality Control in Nuclear Medicine. The CV Mosby Company, Saint Louis. 1977.
Pauwels E K J, Feitsma R I J. Radiochemical Quality Control of Tc-99m-labelled Radiopharmaceuticals. Eur J Nucl Med 1977; 2:97–103.
Fritsberg A R, Huckaby D. Development and Results of Routine Quality Control Procedures for Tc-99m-Im inodiacetate Hepatobiliary Agents. Radiopharmaceuticals II. Proceedings 2nd International Symposium on Radiopharmaceuticals, Seattle, Washington. Soc Nucl Med, New York. 1979.
Unterspann S, Finck W. Chemical Structure and Pharmacokinetics of Tc-99m-labelled Aminomethane Diphosphonic Acid Derivatives. Eur J Nucl Med 1981; 6:527–530.
Deacon J M, Eu PJ, Anderson P, Khan O. Tc-99m-plasmin, a new test for the detection of deep vein thrombosis. Brit J Radiol 1980; 53:673–677.
Nicholson R W, Herman K J, Shilds R A, Testa H J. The Preparation and Composition of HIDA. Eur J Nucl Med 1980; 5:313–317.
Pauwels E. K. J, Feitsma J I R, Vermey P. Composition of Tc-99m-HIDA as a Function of Time after Kit Preparation. Eur J Nucl Med 1981; 6:433–434.
Pedersen B, Kristensen K. Evaluation of Methods for Sizing of Colloidal Radiopharmaceuticals. Eur J Nucl Med 1981;6:521–526.
Frier M, Griffiths P, Ramsey A. The Physical and Chemical Characteristics of Sulfur Colloids. Eur J Nucl Med 1981;6:255–260.
Der M, Ballinger J R, Bowen B M. Decomposition of Tc-99m Pyrophosphate by Peroxides in Pertechnetate used in Preparation. J Nucl Med 1981; 22:645–646.
McLean J R, Rockwell L J, Welsh W J. Comparison of the Rat and Mouse Model for Monitoring the Radiochemical purity of Tc-99m Human Serum Albumin. Radiopharmaceuticals II. Proceedings 2nd International symposium on Radiopharmaceuticals. Seattle, Washington. Soc Nucl Med New York. 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Marqversen, J. (1984). Kit — Hospital Points of View. In: Kristensen, K., Nørbygaard, E. (eds) Safety and efficacy of radiopharmaceuticals. Developments in Nuclear Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6753-3_32
Download citation
DOI: https://doi.org/10.1007/978-94-009-6753-3_32
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6755-7
Online ISBN: 978-94-009-6753-3
eBook Packages: Springer Book Archive